|
|
|
|
| LEADER |
00000pam a2200000 a 4500 |
| 001 |
2738010 |
| 003 |
ICU |
| 005 |
20030524153600.0 |
| 008 |
970206s1997 enka b 001 0 eng c |
| 010 |
|
|
|a 97007044
|
| 020 |
|
|
|a 0865427291
|
| 035 |
|
|
|a (NhCcYBP)YBT 97007044
|
| 035 |
|
|
|a (NhCcYBP)YBP97223110204
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|d NhCcYBP
|d OrLoB-B
|d OCoLC
|
| 050 |
0 |
0 |
|a QR181
|b .R57 1997
|
| 060 |
1 |
0 |
|a QW 504 R719e 1997
|
| 082 |
0 |
0 |
|a 616.07/9
|2 21
|
| 100 |
1 |
|
|a Roitt, Ivan M.
|q (Ivan Maurice)
|0 http://id.loc.gov/authorities/names/n50048195
|1 http://viaf.org/viaf/108123036
|
| 245 |
1 |
0 |
|a Roitt's essential immunology /
|c Ivan M. Roitt.
|
| 246 |
3 |
3 |
|a Essential immunology
|
| 250 |
|
|
|a 9th ed.
|
| 260 |
|
|
|a Oxford ;
|a Malden, MA :
|b Blackwell Science,
|c 1997.
|
| 300 |
|
|
|a xix, 476 p. :
|b ill. (some col.) ;
|c 28 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|g Pt. 1.
|t The Basis of Immunology.
|g 1.
|t Innate immunity.
|g 2.
|t Specific acquired immunity --
|g Pt. 2.
|t The Recognition of Antigen.
|g 3.
|t Antibodies.
|g 4.
|t Membrane receptors for antigen.
|g 5.
|t The primary interaction with antigen --
|g Pt. 3.
|t Technology.
|g 6.
|t Immunochemical techniques.
|g 7.
|t Cellular techniques --
|g Pt. 4.
|t The Acquired Immune Response.
|g 8.
|t The anatomy of the immune response.
|g 9.
|t Lymphocyte activation.
|g 10.
|t The production of effectors.
|g 11.
|t Control mechanisms.
|g 12.
|t Ontogeny and phylogeny --
|g Pt. 5.
|t Immunity to Infection.
|g 13.
|t Adversarial strategies during infection.
|g 14.
|t Prophylaxis --
|g Pt. 6.
|t Clinical Immunology.
|g 15.
|t Immunodeficiency.
|g 16.
|t Hypersensitivity.
|g 17.
|t Transplantation.
|g 18.
|t Tumor immunology.
|g 19.
|t Autoimmune diseases 1 - Scope and etiology.
|g 20.
|t Autoimmune diseases 2 - Pathogenesis, diagnosis and treatment.
|g App. 1.
|t CD Markers.
|
| 650 |
|
0 |
|a Immunology.
|0 http://id.loc.gov/authorities/subjects/sh00005904
|
| 650 |
1 |
2 |
|a Immune System.
|
| 650 |
2 |
2 |
|a Immunity.
|
| 650 |
|
7 |
|a Immunology.
|2 fast
|0 http://id.worldcat.org/fast/fst00968006
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 035 |
|
|
|a (OCoLC)36393844
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i de3e4f73-8cc2-534c-a6e7-3c5cb3c9be92
|s 1ed42fd6-02af-5503-a700-3fc1d2087262
|
| 928 |
|
|
|t Library of Congress classification
|a QR181 .R57 1997
|l JCL
|c JCL-Sci
|i 3243900
|
| 927 |
|
|
|t Library of Congress classification
|a QR181 .R57 1997
|l JCL
|c JCL-Sci
|e CRERAR
|b 46800219
|i 4975742
|
